Results
|
81.
|
|
|
82.
|
|
|
83.
|
|
|
84.
|
|
|
85.
|
|
|
86.
|
|
|
87.
|
|
|
88.
|
|
|
89.
|
|
|
90.
|
|
|
91.
|
|
|
92.
|
|
|
93.
|
|
|
94.
|
XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results. [electronic resource] by
- Cassidy, J
- Clarke, S
- Díaz-Rubio, E
- Scheithauer, W
- Figer, A
- Wong, R
- Koski, S
- Rittweger, K
- Gilberg, F
- Saltz, L
Producer: 20110922
In:
British journal of cancer vol. 105
Availability: No items available.
|
|
95.
|
|
|
96.
|
|
|
97.
|
|
|
98.
|
Retrospective evaluation of toxicity in three different schedules of adjuvant chemotherapy for patients with resected colorectal cancer. TTD Spanish Cooperative Group. [electronic resource] by
- Sastre, J
- Navarro, M
- Aranda, E
- Fonseca, E
- Checa, T
- Alonso, M C
- Gallen, M
- Camps, C
- Antón, A
- Díaz-Rubio, E
Producer: 19991207
In:
Oncology reports vol. 6
Availability: No items available.
|
|
99.
|
A prospective randomized trial of continuous infusion 5-fluorouracil (5-FU) versus 5-FU plus cisplatin in patients with advanced colorectal cancer. A trial of the Spanish Cooperative Group for Digestive Tract Tumor Therapy (T.T.D.). [electronic resource] by
- Díaz-Rubio, E
- Jimeno, J
- Antón, A
- Aranda, E
- Sánchez, J
- Massuti, B
- Cruz-Hernández, J
- Carrato, A
- Martin, M
- Belón, J
Producer: 19920417
In:
American journal of clinical oncology vol. 15
Availability: No items available.
|
|
100.
|
|